Companies to explore

0 results

    No published company or research matches your search. Try a name or ticker.

    Verdict: Invest

    Română
    NASDAQ · United States

    Qualcomm (QCOM)

    Semiconductors

    InvestableWait
    $172.11
    Close
    Oct 16, 2026
    -3.53% last session
    Reported revenue
    $9.95 bn
    Q3 2026
    Annual revenue growth
    -4%
    Q3 2026
    Operating margin
    16.3%
    Q3 2026
    Reported P/E
    19.91×
    2026-10-14
    PRICE PERFORMANCE

    1.Share price

    $172.62+$10.88 (+6.73%)from period start
    One year of daily closes$266$214$161$109Oct 25Jan 26Apr 26Jul 26Oct 26

    Daily closes, adjusted for stock splits. Price return excludes dividends. Hover or tap to explore.

    2.Company news

    View all
    OUR VERDICT

    3.Our verdict

    Waiting for a better price

    The published targets do not meet our required upside.

    Assessed at $172.11 · 12-month horizon

    Analyst price targets · 12 months

    Published analyst targets, compared with our dated share price.

    Average target
    $194.13
    Price potential
    +12.8%
    Analysts
    37
    Low–high range
    $100.00$400.00
    Historical SPY reference · 5 years
    +11.1%
    Average target versus SPY hurdle
    1.7 pp
    Buy threshold below
    $152.00

    Why now

    • The company delivers the operating progress reflected in analyst expectations.

    What would change our view

    • Analyst targets or the reported financial position deteriorate.
    RESEARCH AT PUBLICATION

    4.Investment case at publication

    Qualcomm’s wireless reach meets a tougher profit test

    Patents and smartphone chips give Qualcomm a powerful industry position, but weaker margins put the execution of its expansion beyond handsets under sharper scrutiny.

    Qualcomm’s strength lies in selling chips and licensing the wireless inventions that device makers use. Expansion into automotive and connected devices is an attractive opportunity, but the reported quarter shows that broad technological reach does not guarantee resilient operating profit.

    1. Wireless patents and chip designs give Qualcomm distinct ways to earn revenue across the device industry.

    2. The reported June fiscal quarter brought lower revenue, operating margin and diluted earnings than the same fiscal quarter of the prior year.

    3. Diversification, licensing renewals and the recovery of operating profitability are the key business developments to watch.

    5.Latest quarter

    Qualcomm’s reported fiscal quarter ended in June showed pressure beyond a softer sales result. Revenue declined from the same fiscal quarter of the prior year, while operating income and operating margin also fell against that baseline.

    Reported diluted earnings declined from the same fiscal quarter of the prior year. The sharper deterioration in operating profitability makes the cost of serving those sales a central business concern.

    Published financial metrics and reporting periods
    MetricPeriodValue
    Reported revenueQ3 2026$9.95 bn
    Annual revenue growthQ3 2026-4%
    Reported operating incomeQ3 2026$1.63 bn
    Operating marginQ3 202616.3%
    Profit per share, after dilutionQ3 2026$1.87

    6.The business

    Qualcomm designs chips and licenses wireless technology.

    We like Qualcomm’s position at the heart of wireless devices. It supplies the processors and connectivity technology that manufacturers need, while its patents extend its reach across the industry. Bringing that expertise into cars and connected equipment is an exciting opportunity to build a business that reaches well beyond the smartphone.

    Chip sales and patent licensing earn money differently: customers buy physical products, while licensees pay for rights to use Qualcomm’s inventions. Its latest annual filing says a limited group of customers and licensees has historically contributed a significant share of revenue.

    7.Growth

    Reported June fiscal-quarter revenue declined against both the preceding fiscal quarter and the same fiscal quarter of the prior year. The consolidated figures do not identify whether handset chips, licensing, automotive or connected devices caused the weakness.

    Qualcomm’s annual filing describes diversification beyond mobile handsets as a strategic focus. Automotive offers demanding qualification standards and long product lives, but long customer adoption timelines and added costs make expansion an execution task rather than an immediate substitute for handset demand.

    Revenue history

    $ bn
    Revenue
    Revenue historyConsolidated reported quarterly revenue; compare the same fiscal quarter across years. Unit: $ bn.$13$9.7$6.5$3.2$0Q4 2023 · Revenue: $8.63 bnQ1 2024 · Revenue: $9.94 bnQ2 2024 · Revenue: $9.39 bnQ3 2024 · Revenue: $9.39 bnQ4 2024 · Revenue: $10.24 bnQ1 2025 · Revenue: $11.67 bnQ2 2025 · Revenue: $10.98 bnQ3 2025 · Revenue: $10.37 bnQ4 2025 · Revenue: $11.27 bnQ1 2026 · Revenue: $12.25 bnQ2 2026 · Revenue: $10.6 bnQ3 2026 · Revenue: $9.95 bnQ4 2023Q2 2024Q4 2024Q3 2025Q1 2026Q3 2026Revenue historyConsolidated reported quarterly revenue; compare the same fiscal quarter across years. Unit: $ bn.$13$9.7$6.5$3.2$0Q4 2023 · Revenue: $8.63 bnQ1 2024 · Revenue: $9.94 bnQ2 2024 · Revenue: $9.39 bnQ3 2024 · Revenue: $9.39 bnQ4 2024 · Revenue: $10.24 bnQ1 2025 · Revenue: $11.67 bnQ2 2025 · Revenue: $10.98 bnQ3 2025 · Revenue: $10.37 bnQ4 2025 · Revenue: $11.27 bnQ1 2026 · Revenue: $12.25 bnQ2 2026 · Revenue: $10.6 bnQ3 2026 · Revenue: $9.95 bnQ4 2023Q2 2025Q3 2026

    Consolidated reported quarterly revenue; compare the same fiscal quarter across years.

    View chart data
    Revenue history
    PeriodRevenue ($ bn)
    Q4 2023$8.63
    Q1 2024$9.94
    Q2 2024$9.39
    Q3 2024$9.39
    Q4 2024$10.24
    Q1 2025$11.67
    Q2 2025$10.98
    Q3 2025$10.37
    Q4 2025$11.27
    Q1 2026$12.25
    Q2 2026$10.6
    Q3 2026$9.95

    8.Profitability

    Operating margin measures how much revenue remains after operating costs. It declined from both the preceding fiscal quarter and the same fiscal quarter of the prior year, showing that operating costs absorbed more of sales against each baseline.

    The annual filing identifies reliance on outside manufacturers, assemblers and testing suppliers as a material risk. Access to production capacity matters, while competition in connectivity, low-power computing and on-device artificial intelligence keeps product execution demanding. These are structural risks, not established explanations for the quarter’s margin decline.

    Operating margin

    %
    Operating margin
    Operating marginReported consolidated operating income divided by revenue. Missing provider fields remain unavailable. Unit: %.31.627.523.419.315.2Q4 2023 · Operating margin: 16.34 %Q1 2024 · Operating margin: 29.47 %Q2 2024 · Operating margin: 24.92 %Q3 2024 · Operating margin: 24.44 %Q4 2024 · Operating margin: 24.75 %Q1 2025 · Operating margin: 30.47 %Q2 2025 · Operating margin: 28.42 %Q3 2025 · Operating margin: 26.65 %Q4 2025 · Operating margin: 25.89 %Q1 2026 · Operating margin: 27.47 %Q2 2026 · Operating margin: 21.79 %Q3 2026 · Operating margin: 16.35 %Q4 2023Q2 2024Q4 2024Q3 2025Q1 2026Q3 2026Operating marginReported consolidated operating income divided by revenue. Missing provider fields remain unavailable. Unit: %.31.627.523.419.315.2Q4 2023 · Operating margin: 16.34 %Q1 2024 · Operating margin: 29.47 %Q2 2024 · Operating margin: 24.92 %Q3 2024 · Operating margin: 24.44 %Q4 2024 · Operating margin: 24.75 %Q1 2025 · Operating margin: 30.47 %Q2 2025 · Operating margin: 28.42 %Q3 2025 · Operating margin: 26.65 %Q4 2025 · Operating margin: 25.89 %Q1 2026 · Operating margin: 27.47 %Q2 2026 · Operating margin: 21.79 %Q3 2026 · Operating margin: 16.35 %Q4 2023Q2 2025Q3 2026

    Reported consolidated operating income divided by revenue. Missing provider fields remain unavailable.

    View chart data
    Operating margin
    PeriodOperating margin (%)
    Q4 202316.34
    Q1 202429.47
    Q2 202424.92
    Q3 202424.44
    Q4 202424.75
    Q1 202530.47
    Q2 202528.42
    Q3 202526.65
    Q4 202525.89
    Q1 202627.47
    Q2 202621.79
    Q3 202616.35

    9.Earnings

    Reported diluted earnings represent profit allocated across the weighted-average share count, including potential dilution. They declined from both the preceding fiscal quarter and the same fiscal quarter of the prior year.

    Consolidated net income exceeded operating income in the reported quarter. The available fields do not explain that gap, so the result should not be treated as evidence of stronger underlying operations. The earnings history also contains considerable variation that the available detail cannot fully reconcile.

    Published financial metrics and reporting periods
    MetricPeriodValue
    Other non-operating incomeQ3 2026$0 bn
    Reported consolidated net incomeQ3 2026$2 bn
    Average shares, including potential dilutionQ3 20261.07 bn shares

    Reported diluted EPS

    $
    Diluted EPS
    Reported diluted EPSThe published provider EPS field. No ADR, currency or adjusted-earnings conversion is inferred. Unit: $.$7.5$4.8$2-$0.7-$3.4Q4 2023 · Diluted EPS: $1.32Q1 2024 · Diluted EPS: $2.46Q2 2024 · Diluted EPS: $2.06Q3 2024 · Diluted EPS: $1.88Q4 2024 · Diluted EPS: $2.59Q1 2025 · Diluted EPS: $2.83Q2 2025 · Diluted EPS: $2.52Q3 2025 · Diluted EPS: $2.43Q4 2025 · Diluted EPS: -$2.88Q1 2026 · Diluted EPS: $2.78Q2 2026 · Diluted EPS: $6.88Q3 2026 · Diluted EPS: $1.87Q4 2023Q2 2024Q4 2024Q3 2025Q1 2026Q3 2026Reported diluted EPSThe published provider EPS field. No ADR, currency or adjusted-earnings conversion is inferred. Unit: $.$7.5$4.8$2-$0.7-$3.4Q4 2023 · Diluted EPS: $1.32Q1 2024 · Diluted EPS: $2.46Q2 2024 · Diluted EPS: $2.06Q3 2024 · Diluted EPS: $1.88Q4 2024 · Diluted EPS: $2.59Q1 2025 · Diluted EPS: $2.83Q2 2025 · Diluted EPS: $2.52Q3 2025 · Diluted EPS: $2.43Q4 2025 · Diluted EPS: -$2.88Q1 2026 · Diluted EPS: $2.78Q2 2026 · Diluted EPS: $6.88Q3 2026 · Diluted EPS: $1.87Q4 2023Q2 2025Q3 2026

    The published provider EPS field. No ADR, currency or adjusted-earnings conversion is inferred.

    View chart data
    Reported diluted EPS
    PeriodDiluted EPS ($)
    Q4 2023$1.32
    Q1 2024$2.46
    Q2 2024$2.06
    Q3 2024$1.88
    Q4 2024$2.59
    Q1 2025$2.83
    Q2 2025$2.52
    Q3 2025$2.43
    Q4 2025-$2.88
    Q1 2026$2.78
    Q2 2026$6.88
    Q3 2026$1.87

    10.Cash flow

    For the reported June fiscal quarter, operating cash flow remained positive but declined from the same fiscal quarter of the prior year. Gross cash purchases of property, plant and equipment increased against that baseline, leaving less cash after those purchases.

    For the trailing twelve months ended at the June quarter-end, operating cash flow also exceeded gross cash purchases of property, plant and equipment. This derived remainder excludes asset-sale proceeds, intangible investments, leases and noncash commitments. It is not an issuer-defined free-cash-flow measure or a complete measure of investment spending.

    Published financial metrics and reporting periods
    MetricPeriodValue
    Cash generated by operationsTTM 2026-06-28$12.4 bn
    Cash after investmentsTTM 2026-06-28$10.42 bn
    Cash generated by operationsQ3 2026$0.99 bn
    Building and equipment investmentsQ3 2026$0.5 bn
    Cash after investmentsQ3 2026$0.5 bn

    Cash generated versus cash invested

    $ bn
    Operating cash flowGross cash PPE purchasesOCF less gross PPE purchases
    Cash generated versus cash investedMassive reported quarterly operating cash flow less gross cash PPE purchases, calculated in code. PPE sales, intangible investments, leases and noncash commitments are excluded. This is separate from a broader issuer-defined productive-assets cash measure. Missing fields remain unavailable. Unit: $ bn.$5.3$4$2.6$1.2-$0.2Q4 2024 · Operating cash flow: $2.65 bnQ1 2025 · Operating cash flow: $4.59 bnQ2 2025 · Operating cash flow: $2.55 bnQ3 2025 · Operating cash flow: $2.88 bnQ4 2025 · Operating cash flow: $4 bnQ1 2026 · Operating cash flow: $4.97 bnQ2 2026 · Operating cash flow: $2.45 bnQ3 2026 · Operating cash flow: $0.99 bnQ4 2024 · Gross cash PPE purchases: $0.26 bnQ1 2025 · Gross cash PPE purchases: $0.28 bnQ2 2025 · Gross cash PPE purchases: $0.21 bnQ3 2025 · Gross cash PPE purchases: $0.29 bnQ4 2025 · Gross cash PPE purchases: $0.41 bnQ1 2026 · Gross cash PPE purchases: $0.55 bnQ2 2026 · Gross cash PPE purchases: $0.53 bnQ3 2026 · Gross cash PPE purchases: $0.5 bnQ4 2024 · OCF less gross PPE purchases: $2.39 bnQ1 2025 · OCF less gross PPE purchases: $4.31 bnQ2 2025 · OCF less gross PPE purchases: $2.34 bnQ3 2025 · OCF less gross PPE purchases: $2.58 bnQ4 2025 · OCF less gross PPE purchases: $3.59 bnQ1 2026 · OCF less gross PPE purchases: $4.42 bnQ2 2026 · OCF less gross PPE purchases: $1.92 bnQ3 2026 · OCF less gross PPE purchases: $0.5 bnQ4 2024Q1 2025Q3 2025Q4 2025Q2 2026Q3 2026Cash generated versus cash investedMassive reported quarterly operating cash flow less gross cash PPE purchases, calculated in code. PPE sales, intangible investments, leases and noncash commitments are excluded. This is separate from a broader issuer-defined productive-assets cash measure. Missing fields remain unavailable. Unit: $ bn.$5.3$4$2.6$1.2-$0.2Q4 2024 · Operating cash flow: $2.65 bnQ1 2025 · Operating cash flow: $4.59 bnQ2 2025 · Operating cash flow: $2.55 bnQ3 2025 · Operating cash flow: $2.88 bnQ4 2025 · Operating cash flow: $4 bnQ1 2026 · Operating cash flow: $4.97 bnQ2 2026 · Operating cash flow: $2.45 bnQ3 2026 · Operating cash flow: $0.99 bnQ4 2024 · Gross cash PPE purchases: $0.26 bnQ1 2025 · Gross cash PPE purchases: $0.28 bnQ2 2025 · Gross cash PPE purchases: $0.21 bnQ3 2025 · Gross cash PPE purchases: $0.29 bnQ4 2025 · Gross cash PPE purchases: $0.41 bnQ1 2026 · Gross cash PPE purchases: $0.55 bnQ2 2026 · Gross cash PPE purchases: $0.53 bnQ3 2026 · Gross cash PPE purchases: $0.5 bnQ4 2024 · OCF less gross PPE purchases: $2.39 bnQ1 2025 · OCF less gross PPE purchases: $4.31 bnQ2 2025 · OCF less gross PPE purchases: $2.34 bnQ3 2025 · OCF less gross PPE purchases: $2.58 bnQ4 2025 · OCF less gross PPE purchases: $3.59 bnQ1 2026 · OCF less gross PPE purchases: $4.42 bnQ2 2026 · OCF less gross PPE purchases: $1.92 bnQ3 2026 · OCF less gross PPE purchases: $0.5 bnQ4 2024Q4 2025Q3 2026

    Massive reported quarterly operating cash flow less gross cash PPE purchases, calculated in code. PPE sales, intangible investments, leases and noncash commitments are excluded. This is separate from a broader issuer-defined productive-assets cash measure. Missing fields remain unavailable.

    View chart data
    Cash generated versus cash invested
    PeriodOperating cash flow ($ bn)Gross cash PPE purchases ($ bn)OCF less gross PPE purchases ($ bn)
    Q4 2024$2.65$0.26$2.39
    Q1 2025$4.59$0.28$4.31
    Q2 2025$2.55$0.21$2.34
    Q3 2025$2.88$0.29$2.58
    Q4 2025$4$0.41$3.59
    Q1 2026$4.97$0.55$4.42
    Q2 2026$2.45$0.53$1.92
    Q3 2026$0.99$0.5$0.5

    11.Balance sheet

    Cash and short-term investments provide liquidity, but together they are below current borrowings plus noncurrent debt and capital lease obligations. Qualcomm therefore has financial resources alongside meaningful financing commitments.

    Current borrowings require nearer-term attention than noncurrent obligations. The available figures do not establish refinancing terms or a repayment schedule, so liquidity should be assessed alongside ongoing cash generation rather than in isolation.

    Published financial metrics and reporting periods
    MetricPeriodValue
    Cash and readily available funds2026-06-28$4.53 bn
    Short-term investments2026-06-28$3.77 bn
    Short-term debt2026-06-28$2.49 bn
    Long-term debt and leases2026-06-28$12.78 bn

    12.Valuation

    The current analyst targets and SPY comparison are shown in Our verdict.

    View the current assessment

    13.What we are watching

    Watch whether operating margin stabilizes alongside sales, and whether reported quarterly cash generation supports investment more comfortably. Product-level evidence would help distinguish handset conditions from progress in automotive and connected devices.

    Licensing agreement renewals and continued development of the patent portfolio matter to the licensing franchise. The latest annual filing also highlights China exposure, possible customer use of internally designed chips, trade restrictions and supplier concentration as important business risks.